Lantern Pharma Inc (NAS:LTRN)
$ 3.27 -0.01 (-0.3%) Market Cap: 35.20 Mil Enterprise Value: 2.27 Mil PE Ratio: 0 PB Ratio: 1.14 GF Score: 39/100

Q2 2022 Lantern Pharma Inc. Earnings Call Transcript

Aug 08, 2022 / 08:30PM GMT
Release Date Price: $5.6 (+2.56%)
Nicole Leber
Lantern Pharma Inc. - IR Associate, Finance & Administrative Coordinator

Good afternoon, everybody. I'm Nicole Leber with Investor Relations here at Lantern Pharma, and welcome to our second quarter 2022 earnings call. I will be your host for today's call. As a reminder, this call is being recorded. (Operator Instructions) A webcast replay of today's conference call will be available on our website at lanternpharma.com shortly after the call.

We issued a press release after the market closed today, summarizing our financial results and progress across the company for the second quarter of 2022. A copy of this release is available through our website at lanternpharma.com, where you will also find a link to the slides that management will be referencing on today's call.

I would like to remind everyone that remarks about future expectations, performance, estimates and prospectus constitute forward-looking statements for purposes of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Lantern Pharma cautions that these forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot